Ping Chen

Prevalence of Chronic Obstructive Pulmonary Disease in China

Nanshan Zhong, Chen Wang, Wan-zhen Yao et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 756 citations

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

Jinping Zheng, Jian Kang, Shaoguang Huang et al. · The Lancet · 2008 · 353 citations

Acute Lung Injury, Advanced Lung Disease, Pharmacology +7

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

Jinping Zheng, Fuqiang Wen, Chunxue Bai et al. · The Lancet Respiratory Medicine · 2014 · 248 citations

Advanced Lung Disease, Pharmacology, N-acetylcysteine 600 +5

A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation

Hui‐Hui Yang, Jia‐Xi Duan, Shaokun Liu et al. · Theranostics · 2020 · 230 citations · Full text